.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Federal Trade Commission
Queensland Health
Fish and Richardson
Accenture
Citi
Merck
Boehringer Ingelheim
Baxter
McKinsey

Generated: January 16, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to United Kingdom Patent: 0422307.9

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
ProvensisVARITHENApolidocanolSOLUTION;INTRAVENOUS205098-001Nov 25, 2013RXYesYes➤ Subscribe➤ SubscribeYY
ProvensisVARITHENApolidocanolSOLUTION;INTRAVENOUS205098-001Nov 25, 2013RXYesYes➤ Subscribe➤ SubscribeY
ProvensisVARITHENApolidocanolSOLUTION;INTRAVENOUS205098-001Nov 25, 2013RXYesYes➤ Subscribe➤ SubscribeYYA METHOD OF INTRAVENOUS INJECTION USING ULTRASOUND GUIDANCE, ADMINISTERED VIA A SINGLE CANNULA INTO THE LUMEN OF THE TARGET INCOMPETENT TRUNK VEINS OR BY DIRECT INJECTION INTO VARICOSITIES
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist